Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NOde302
Previous Study | Return to List | Next Study

Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of PSVT. NODE-302

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03635996
Recruitment Status : Recruiting
First Posted : August 17, 2018
Last Update Posted : September 29, 2020
Sponsor:
Collaborator:
Medpace, Inc.
Information provided by (Responsible Party):
Milestone Pharmaceuticals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : January 2022